A Multicenter Phase II Study of Pembrolizumab (MK-3475) in Patients with Advanced Small Bowel Adenocarcinoma S

Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery »